Amino Acid Interference in the Bacterial Reverse Mutation (Ames) Test: OECD Test Guideline 471.

被引:0
|
作者
Myhre, A. [1 ]
Faranda, A. [1 ]
Davis, F. [1 ]
Donner, E. M. [1 ]
机构
[1] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE USA
关键词
D O I
暂无
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
GT-83
引用
收藏
页码:S79 / S79
页数:1
相关论文
共 43 条
  • [32] Synacinn™: Bacterial reverse mutation test data in five histidine-requiring strains of Salmonella Typhimurium
    Zainol, Siti Nurazwa
    Fadhlina, Anis
    Rentala, Sri Vijaya
    Yalaka, Manjula
    Vatsavai, Leela Krishna
    Pillai, Renuka
    Ismail, Hassan Fahmi
    Majid, Fadzilah Adibah Abdul
    DATA IN BRIEF, 2021, 36
  • [33] Appropriate in vivo follow-up assays to an in vitro bacterial reverse mutation (Ames) test positive investigational drug candidate (active pharmaceutical ingredient), drug-related metabolite, or drug-related impurity
    Robison, Timothy W.
    Heflich, Robert H.
    Manjanatha, Mugimane G.
    Elespuru, Rosalie
    Atrakchi, Aisar
    Mei, Nan
    Ding, Wei
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2021, 868
  • [34] Identifying germ cell mutagens using OECD test guideline 488 (transgenic rodent somatic and germ cell gene mutation assays) and integration with somatic cell testing
    Marchetti, Francesco
    Aardema, Marilyn J.
    Beevers, Carol
    van Benthem, Jan
    Godschalk, Roger
    Williams, Andrew
    Yauk, Carole L.
    Young, Robert
    Douglas, George R.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2018, 832 : 7 - 18
  • [35] A comparative analysis of the ability of various S9 compositions to metabolically activate N- nitrosamines to mutagens in the bacterial reverse mutation test
    Bringezu, F.
    Simon, S.
    Dieckhoff, J.
    TOXICOLOGY LETTERS, 2024, 399 : S219 - S219
  • [36] Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test
    Mee-Young Lee
    Chang-Seob Seo
    Ji-Young Kim
    Hyeun-Kyoo Shin
    BMC Complementary and Alternative Medicine, 14
  • [37] The Genetic Activity of Anthramycin, Tomaymycin and Sibiromycin in Bacterial Forward- and Reverse-Mutation Assays and in the Mouse Bone-Marrow Micronucleus Test
    Gairola, C.
    Thomas, H.
    Szeinbach, S. L.
    Lubawy, W. C.
    JOURNAL OF APPLIED TOXICOLOGY, 1983, 3 (06) : 317 - 320
  • [38] Genotoxicity evaluation of Guibi-Tang extract using an in vitro bacterial reverse mutation assay, chromosome aberration assay, and in vivo micronucleus test
    Lee, Mee-Young
    Seo, Chang-Seob
    Kim, Ji-Young
    Shin, Hyeun-Kyoo
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 14
  • [39] Modifications of the bacterial reverse mutation test reveals mutagenicity of TiO2 nanoparticles and byproducts from a sunscreen TiO2-based nanocomposite
    Jomini, Stephane
    Labille, Jerome
    Bauda, Pascale
    Pagnout, Christophe
    TOXICOLOGY LETTERS, 2012, 215 (01) : 54 - 61
  • [40] Identifying germ cell mutagens using OECD test guideline 488 (transgenic rodent somatic and germ cell Gene mutation assays) and integration with somatic cell testing (vol 832, pg 7, 2018)
    Marchetti, Francesco
    Aardema, Marilyn J.
    Beevers, Carol
    van Benthem, Jan
    Godschalk, Roger
    Williams, Andrew
    Yauk, Carole L.
    Young, Robert
    Douglas, George R.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2019, 844 : 70 - 71